Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CytRx Announces Patent Issued for Aldoxorubicin in the Treatment of Brain Cancer

americanpharmaceuticalreviewMay 10, 2019

Tag: CytRx , Aldoxorubicin , brain , Cancer

PharmaSources Customer Service